Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan

NCT02251613 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Olopatadine HCl ophthalmic solution, 0.1%
DRUG: Epinastine HCl ophthalmic solution, 0.05%

Sponsor

Alcon Research